Schuyler J.Schouten

Partner

Washington + 1.202.879.3844

Schuyler Schouten counsels and represents clients in international trade, foreign investment, and national security matters. He draws on government and private sector experience encompassing regulatory and constitutional counseling, litigation, transactions, and crisis management.

Schuyler has extensive experience, both in and out of government, with the laws, regulations, and Presidential directives affecting international transactions and supply chains. He represents clients in investment reviews by the Committee on Foreign Investment in the United States (CFIUS) and helps review and design deals to mitigate CFIUS risks. He advises clients on economic sanctions administered by the Office of Foreign Assets Control (OFAC), including by vetting partners, reviewing compliance programs, and assisting with license requests. He advises on tariffs, Customs and Border Protection (CBP) import restrictions, and Defense Production Act (DPA) orders.

Schuyler regularly assists companies in navigating government directives for which no case law or public guidance exists as well as in contesting government assertions of authority. His representations include apparel, energy, pharmaceutical, food, technology, and software clients.

Schuyler joined Jones Day from the White House, where he served as Senior Associate Counsel to the President and Deputy Legal Advisor to the National Security Council (NSC), advising on sanctions, CFIUS, technology regulation, and foreign relations law. Schuyler worked in the New York and Washington offices of a major law firm and was an aide to former Secretary of State Henry Kissinger, who described him as "indispensable and indefatigable." Schuyler is a member of the Council on Foreign Relations and the Exchequer Club of Washington, D.C.

Erfahrung

  • Riverside invests in CISJones Day represented The Riverside Company in connection with its minority investment in CIS Secure Computing, Inc. (CIS), a leading provider of secure endpoint communications solutions to government agencies.
  • Uniphore raises capital in Series D roundJones Day represented Uniphore Technologies Inc., a conversational AI platform providing automation, analytics, assistant and security services, in its issuance of Series D Preferred Stock, which was led by Sorenson Capital Partners.
  • Bpifrance participates in $42 million Series B financing round of SightCallJones Day represented Bpifrance in the $42 million Series B round of financing of SightCall, Inc., the leading augmented reality (AR)-powered visual assistance platform, led by InfraVia Capital Partners.
  • PureCycle Technologies combines with Roth CH Acquisition I Co.Jones Day advised PureCycle Technologies LLC ("PureCycle") in its business combination with Roth CH Acquisition I Co. ("Roth SPAC"), a publicly-traded special purpose acquisition corporation backed by Roth Capital Partners and Craig-Hallum Capital Group, and Roth CH Acquisition I Co. Parent Corp., a wholly owned subsidiary of Roth CH ("Holdings"), among others.
  • Cardinal Health to sell its Cordis business to Hellman & Friedman for approximately $1 billionJones Day is advising Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • American Industrial Partners to acquire High Pressure Solutions Segment of Ingersoll Rand for $300 millionJones Day is advising American Industrial Partners in its $300 million acquisition of a majority interest in the High Pressure Solutions Segment of Ingersoll Rand, a premier market leader in the manufacturing, service, and repair of high-pressure pumps and related consumables in the upstream energy market.
  • Manufacturers challenge tariffs in Court of International TradeJones Day represents several manufacturers challenging tariffs promulgated by the United States Trade Representative pursuant to Section 301 of the Trade Act.
  • Integer Holdings Corporation develops employee programming to mitigate the spread of COVID-19 within the workplaceJones Day represented Integer Holdings Corporation during the COVID-19 crisis to develop appropriate protocols and policies for implementing an employee temperature screening program, a face covering program, and return to work policies for employees suffering from COVID-19, respiratory illness, or exposure to individuals with COVID-19.
  • Luxury department store chain develops employee programming to mitigate spread of COVID-19 within workplaceJones Day represented a luxury department store chain during the COVID-19 crisis to develop appropriate protocols and policies for implementing an employee temperature screening program, a face covering program, work from home and return to work policies for employees suffering from COVID-19, respiratory illness, or exposure to individuals with COVID-19.
  • Major American manufacturer reviews PREP Act immunityJones Day advised a major American manufacturer during the COVID-19 pandemic on obtaining immunity from liability for the manufacture and distribution of covered countermeasures under the Public Readiness and Emergency Preparedness Act (PREP Act).
  • Global manufacturing company responds to disclosure of potential vulnerabilities in its productsJones Day led a global manufacturing company's response to the disclosure of potential vulnerabilities in its products.
  • Vortragstätigkeit

    • June 17, 2020
      Cyber Supply Chain and the Cybersecurity Maturity Model Certification (CMMC): Concerns, Considerations, and Practical Solutions
    • March 11, 2020
      Coronavirus Response: What In-House Counsel Need to Know
    • October 23, 2019
      United States International Trade Commission 13th Annual Services Roundtable
    • September 19, 2019
      Edward Bennett Williams Inn of Court Panel Discussion on Sanctions, Export Controls, and the Foreign Agents Registration Act
    • July 12, 2019
      Weathering Trade War Turbulence: A Perspective From Washington, DC
    *We use cookie to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.